Exosomes secreted by Fusobacterium nucleatum-infected colon cancer cells transmit resistance to oxaliplatin and 5-FU by delivering hsa_circ_0004085

J Nanobiotechnology. 2024 Feb 15;22(1):62. doi: 10.1186/s12951-024-02331-9.

Abstract

Background: A large number of Fusobacterium nucleatum (Fn) are present in colorectal cancer (CRC) tissues of patients who relapse after chemotherapy, and Fn has been reported to promote oxaliplatin and 5-FU chemoresistance in CRC. Pathogens such as bacteria and parasites stimulate exosome production in tumor cells, and the regulatory mechanism of exosomal circRNA in the transmission of oxaliplatin and 5-FU chemotherapy resistance in Fn-infected CRC remains unclear.

Methods: Hsa_circ_0004085 was screened by second-generation sequencing of CRC tissues. The correlation between hsa_circ_0004085 and patient clinical response to oxaliplatin/5-FU was analyzed. Exosome tracing experiments and live imaging systems were used to test the effect of Fn infection in CRC on the distribution of hsa_circ_0004085. Colony formation, ER tracking analysis and immunofluorescence were carried out to verify the regulatory effect of exosomes produced by Fn-infected CRC cells on chemotherapeutic resistance and ER stress. RNA pulldown, LC-MS/MS analysis and RIP were used to explore the regulatory mechanism of downstream target genes by hsa_circ_0004085.

Results: First, we screened out hsa_circ_0004085 with abnormally high expression in CRC clinical samples infected with Fn and found that patients with high expression of hsa_circ_0004085 in plasma had a poor clinical response to oxaliplatin/5-FU. Subsequently, the circular structure of hsa_circ_0004085 was identified. Fn infection promoted hsa_circ_0004085 formation by hnRNP L and packaged hsa_circ_0004085 into exosomes by hnRNP A1. Exosomes produced by Fn-infected CRC cells transferred hsa_circ_0004085 between cells and delivered oxaliplatin/5-FU resistance to recipient cells by relieving ER stress. Hsa_circ_0004085 enhanced the stability of GRP78 mRNA by binding to RRBP1 and promoted the nuclear translocation of ATF6p50 to relieve ER stress.

Conclusions: Plasma levels of hsa_circ_0004085 are increased in colon cancer patients with intracellular Fn and are associated with a poor response to oxaliplatin/5-FU. Fn infection promoted hsa_circ_0004085 formation by hnRNP L and packaged hsa_circ_0004085 into exosomes by hnRNP A1. Exosomes secreted by Fn-infected CRC cells deliver hsa_circ_0004085 between cells. Hsa_circ_0004085 relieves ER stress in recipient cells by regulating GRP78 and ATF6p50, thereby delivering resistance to oxaliplatin and 5-FU.

Keywords: Chemoresistance of colon cancer; Endoplasmic reticulum stress; Exosomes; Fusobacterium nucleatum; hsa_circ_0004085.

MeSH terms

  • Cell Proliferation
  • Chromatography, Liquid
  • Colonic Neoplasms* / drug therapy
  • Colonic Neoplasms* / metabolism
  • Colorectal Neoplasms* / metabolism
  • Endoplasmic Reticulum Chaperone BiP
  • Exosomes* / metabolism
  • Fluorouracil / pharmacology
  • Fluorouracil / therapeutic use
  • Fusobacterium nucleatum / genetics
  • Fusobacterium nucleatum / metabolism
  • Heterogeneous Nuclear Ribonucleoprotein A1 / metabolism
  • Heterogeneous-Nuclear Ribonucleoprotein L* / metabolism
  • Humans
  • MicroRNAs* / metabolism
  • Oxaliplatin / metabolism
  • Oxaliplatin / pharmacology
  • Oxaliplatin / therapeutic use
  • Tandem Mass Spectrometry

Substances

  • Oxaliplatin
  • Heterogeneous Nuclear Ribonucleoprotein A1
  • Endoplasmic Reticulum Chaperone BiP
  • Heterogeneous-Nuclear Ribonucleoprotein L
  • Fluorouracil
  • MicroRNAs